Cybin (CYBN.NE) announced it has filed their 13th provisional patent application and is building out its digital therapeutics strategy. Cybin did not go into detail about the patent application,…
Mushrooms
COMPASS Pathways (CMPS.Q) signed an MOU with South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience (IoPPN) at King’s College London. The…
Numinus Wellness (NUMI.V) announced they are going to acquire Neurology Centre of Toronto (NCT), pursuant to a purchase agreement from July 2, 2021. To acquire the centre, Numinus will…
Cybin (CYBN.NE) announced that they have entered into an exclusive research and development collaboration agreement with TMS NeuroHealth Centers, a wholly-owned subsidiary of Greenbrook TMS (GTMS.T). The agreement will…
Revive Therapeutics (RVV.C) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. RVV holds 13 patents (issued and…
Delic Corp (DELC.C) announced that their wholly-owned subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent. Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise,…
Delic Holdings (DELC.C) announced their recently acquired entity Complex Biotech Discovery Ventures (CBDV) has been rebranded as Delic Labs. Delic Labs is a federally authorized psilocybin and cannabis research…
Cybin (CYBN.NE) announced that their wholly-owned subsidiary, Adelia Therapeutics, has achieved certain earn-out milestones for the period commencing January 1, 2021. The terms of the milestone earnings were agreed…
Nova Mentis Life Science (NOVA.C) announced they have received Canadian approval for their North American autism clinical study. They received Institutional Review Board (IRB) approval in Canada on its…
Revive Therapeutic (RVV.C) announced they have entered into an agreement with the University of Health Sciences Antigua (UHSA) to collaborate with Revive on their novel psychedelic-assisted therapies and pioneering…